Enhancing Hair Regrowth In Alopecia Areata: The Power Duo Of CO2 Fractional Laser And Bimatoprost

April 2025 in “ Archives of Dermatological Research ”

Ahmed H. Nouh, Ayaat Abd Elghany Behairy, Fatma Badr El-Koumy, Ahmed Mohamed Abdel Aal, Maryna S. Zhuravlova

CO2 fractional laser Bimatoprost Alopecia Areata hair regrowth hair density pigmentation hair thickness Latisse

From the encyclopedia

Bimatoprost →

a synthetic prostamide used to treat eyelashes also shows promise for stimulating hair growth on scalp

Alopecia Areata →

autoimmune disorder causing patchy hair loss

Studysummary In this study, the combination of CO2 fractional laser therapy with Bimatoprost 0.03% was found to be more effective in promoting hair regrowth in Alopecia Areata patients than laser therapy alone, with higher response rates and minimal adverse effects reported. Our plain-language summary of this paper — not a Tressless recommendation.

This study conducted at Al-Azhar University Hospital evaluated the effectiveness of combining CO2 fractional laser therapy with Bimatoprost 0.03% solution for treating Alopecia Areata (AA) in 60 patients. Participants were divided into two groups: one receiving both treatments and the other receiving only laser therapy. Results showed that the combination therapy group had a significantly higher response rate (80% vs. 40%, p=0.025) with faster and more pronounced hair regrowth, improved hair density, pigmentation, and thickness. Minimal adverse effects were reported. The study concludes that this combination therapy is a safe and effective treatment for AA, suggesting further research with larger sample sizes and longer follow-up periods to confirm these findings.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

14 / 14 results

research Lasers in the Management of Alopecia: A Review of Established Therapies and Advances in Treatment

April 2024 in “Lasers in medical science”

This study reviews the use of lasers and light therapies as treatment options for managing the two most common types of alopecia—androegenetic alopecia and alopecia areata—highlighting that existing FDA-approved drugs like minoxidil and finasteride are partially effective, necessitating additional therapeutic approaches.

research Principles and Clinical Applications of Transcutaneous Laser-Assisted Drug Delivery: A Narrative Review

6 citations , January 2024 in “Scars Burns & Healing”

This article reviews 12 clinical applications for transcutaneous laser-assisted drug delivery in skin disorders and concludes that it has potential for broader treatment use.

research Alopecia Areata: An Updated Review for 2023

91 citations , May 2023 in “Journal of Cutaneous Medicine and Surgery”

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

research The Efficacy of Topical Prostaglandin Analogs for Hair Loss: A Systematic Review and Meta-Analysis

1 citations , March 2023 in “Frontiers in Medicine”

This meta-analysis found that topical prostaglandin analogs could significantly improve hair length and density in patients with hair loss, compared to placebo, without notable safety differences.

research Emerging Drugs for the Treatment of Alopecia Areata

7 citations , October 2022 in “Expert opinion on emerging drugs”

This review reports on new and effective drug developments for treating severe alopecia areata, including oral baricitinib, but emphasizes that no treatment guarantees permanent remission or works for all patients, with high recurrence rates after stopping medication.

research New and Emerging Therapies for Alopecia Areata

46 citations , April 2020 in “Drugs”

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

research Efficacy of Fractional Lasers in Treating Alopecia: A Literature Review

25 citations , August 2017 in “Lasers in Medical Science”

This literature review reported that fractional lasers, like the 1550-nm nonablative erbium-glass laser, may enhance hair regrowth by stimulating a wound healing process, but more randomized controlled trials are needed to confirm their effectiveness and optimize treatment parameters.

research Alopecia Areata: Part 2: Treatment

14 citations , September 2015 in “PubMed”

This review discusses treatment strategies for alopecia areata and emphasizes the importance of primary care physicians recognizing and managing the condition, with referrals to dermatologists for more severe cases.

research Promising Alternative Clinical Uses of Prostaglandin F2α Analogs: Beyond the Eyelashes

31 citations , January 2015 in “Journal of The American Academy of Dermatology”

This review discusses the potential applications of prostaglandin F2α analogs for certain types of alopecia and hypopigmentation, but reports no new experimental results.

research Bimatoprost Versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study

36 citations , January 2015 in “Dermatology”

In this study, bimatoprost solution showed better results than corticosteroid in terms of rapidity, percentage of hair regrowth, and side effects for treating scalp alopecia areata.

research Clinical Effects of Non-Ablative and Ablative Fractional Lasers on Various Hair Disorders: A Case Series of 17 Patients

46 citations , March 2013 in “Journal of Cosmetic and Laser Therapy”

This study found that non-ablative and/or ablative fractional lasers promoted hair growth in patients with certain uncommon hair disorders, though effectiveness varied among different conditions.

The Prostamide-Related Glaucoma Therapy, Bimatoprost, Offers a Novel Approach for Treating Scalp Alopecias